With a market capitalization (market cap) of $4.55B — a measure of how much the company is worth — Celcuity Inc. is the 1492nd most valuable company in Healthcare as of August 18, 2026. Shares trade at $93.24, up +0.87% on the day.
of 2,587
price ÷ annual EPS
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
Celcuity, Inc. operates as a cellular analysis company. The company discovers new cancer sub-types and commercializing diagnostic tests designed to improve the clinical outcomes of cancer patients treated with targeted therapies. The firm's proprietary CELx diagnostic platform is the commercially ready technology that uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the targeted therapy that treats it. The company was founded by Brian F. Sullivan and Lance G. Laing in January 2012 and is headquartered in Minneapolis, MN.
Visit websiteAs of August 18, 2026, Celcuity Inc. (CELC) is worth $4.55B — this is its market capitalization, the total value of all its outstanding shares.
Celcuity Inc.’s market cap is $4.55B, which ranks it #1492 among the most valuable companies in the Healthcare sector tracked on MarketCapLens.
Celcuity Inc. (CELC) shares trade at $93.24, up 0.87% on the day, as of August 18, 2026.
Fundamentals are annual. Figures labeled with their fiscal year.
FY 2025